VA
Valneva SE
VALN · NASDAQ
$6.56 +0.15% (+$0.01)
1M -2.81%
Market Cap 541.7M €
P/E Ratio -
Div. Yield -
ROE 152.63%
Piotroski F-Score Weak
1/9Valuation
32 /100
Expensive P/B 6.68x
P/S 3.77x
EV/EBITDA N/A
Growth
0 /100
Declining Book val. growth 21.54%
Rev. growth 21.52%
FCF growth N/A
Profitability
4 /100
Weak Net margin 110.21%
Op. margin 80.93%
FCF margin 59.70%
Quality
5 /100
Poor ROE 152.63%
ROA 40.75%
Asset turnover 0.37x
Debt
23 /100
High Current ratio 2.16x
Int. coverage -2.83x
Debt/Equity 2.59x
Stability
16 /100
Unstable Rev. volatility 37.20%
EPS volatility 428.59%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o VALN
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Thomas Lingelbach
Employees
674
Headquarters
Saint-Herblain
Prihajajoči dogodki
19 NOV.
Earnings
Upcoming earnings report